Colgate-Palmolive Company (NYSE:CL) today reported worldwide Net sales
of $3,884 million in first quarter 2019, a decrease of 3.0% versus first
quarter 2018. Global unit volume increased 1.0%, pricing increased 2.0%
and foreign exchange was negative 6.0%. Organic sales (Net sales
excluding the impact of foreign exchange, acquisitions and divestments)
increased 3.0%.
Net income and Diluted earnings per share in first quarter 2019 were
$560 million and $0.65, respectively. Net income in first quarter 2019
included $22 million ($0.02 per diluted share) of aftertax charges
resulting from the Company’s Global Growth and Efficiency Program.
Net income and Diluted earnings per share in first quarter 2018 were
$634 million and $0.72, respectively. Net income in first quarter 2018
included $20 million ($0.02 per diluted share) of aftertax charges
resulting from the Global Growth and Efficiency Program.
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Net income in first quarter 2019 was $582
million, a decrease of 11% versus first quarter 2018, and Diluted
earnings per share in first quarter 2019 was $0.67, a decrease of 9%
versus first quarter 2018.
Gross profit margin was 58.9% in first quarter 2019 versus 60.2% in
first quarter 2018. Excluding charges resulting from the Global Growth
and Efficiency Program in both periods, Gross profit margin was 59.2% in
first quarter 2019, a decrease of 110 basis points versus the year ago
quarter as higher raw and packaging material costs, which included
foreign exchange transaction costs, were partially offset by cost
savings from the Company’s funding-the-growth initiatives and higher
pricing.
Selling, general and administrative expenses were 35.1% of Net sales in
first quarter 2019 versus 34.8% of Net sales in first quarter 2018.
Excluding charges resulting from the Global Growth and Efficiency
Program in both periods, Selling, general and administrative expenses
increased by 30 basis points versus the year ago quarter to 35.0% of Net
sales in first quarter 2019 due to increased advertising investment
partially offset by lower overhead expenses, both as a percentage of Net
sales. On an absolute basis, worldwide advertising investment increased
3% to $429 million versus $416 million in the year ago quarter.
Operating profit decreased to $879 million in first quarter 2019
compared to $983 million in first quarter 2018. Excluding charges
resulting from the Global Growth and Efficiency Program in both periods,
Operating profit was $907 million in first quarter 2019, a decrease of
10% versus first quarter 2018. Operating profit margin was 22.6% in
first quarter 2019 versus 24.6% in first quarter 2018. Excluding charges
resulting from the Global Growth and Efficiency Program in both periods,
Operating profit margin was 23.4% in first quarter 2019, a decrease of
180 basis points versus the year ago quarter. This decrease in Operating
profit margin was primarily due to a decrease in Gross profit and an
increase in Selling, general and administrative expenses, both as a
percentage of Net sales.
Net cash provided by operations year to date was $605 million compared
to $616 million in the comparable 2018 period. Working capital as a
percentage of Net sales was negative 3.9% compared to negative 2.7% in
the year ago period.
Noel Wallace, President and Chief Executive Officer, commented on the
first quarter results, “We are pleased with the improvement in organic
sales growth this quarter and that the growth was broad based, with
emerging markets and developed markets each growing 3.0%.
“We believe our plans to accelerate growth are beginning to pay off, as
the stronger organic sales growth we delivered in the quarter had a
better balance between pricing and volume growth than we saw in the
fourth quarter of 2018. This growth was led by our toothpaste and Hill's
businesses.
“Advertising investment increased in absolute dollars and as a percent
to sales versus first quarter 2018, with increases as a percent to sales
in every division.
“Colgate’s leadership of the global toothpaste market continued during
the quarter with our global market share at 41.7% year to date. Our
global leadership in manual toothbrushes also continued with Colgate’s
global market share in that category at 31.6% year to date.”
Mr. Wallace continued, “As we look ahead, based on current spot rates,
we continue to expect 2019 net sales to be flat to up low-single-digits,
with organic sales growth of 2% to 4% as we continue to plan for
increased investment behind our brands, higher pricing and strong
innovation, led by the relaunches of Colgate Total and Hill’s Science
Diet and our continued focus on naturals.
“We are investing in expanding our portfolio offerings by bringing
brands like elmex and meridol into new markets and by broadening our
eCommerce offerings, building on our strong eCommerce growth in 2018. We
are also continuing to increase our investment behind our professional
skin care businesses, Elta MD and PCA Skin.
“On a GAAP basis, based on current spot rates, we expect gross margin
expansion and a low-single-digit decline in earnings per share in 2019.
“Excluding charges resulting from the Global Growth and Efficiency
Program in both 2018 and 2019, the charge related to U.S. tax reform in
2018 and the benefit from a foreign tax matter in 2018, based on current
spot rates, we continue to plan for a year of gross margin expansion,
increased advertising investment and a mid-single-digit decline in
earnings per share.”
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate
on first quarter results. To access this call as a webcast, please go to
Colgate’s website at http://www.colgatepalmolive.com.
The following are comments about divisional performance for first
quarter 2019 versus the year ago period. See attached Geographic Sales
Analysis Percentage Changes and Segment Information tables for
additional information on divisional net sales and operating profit.
North America (22% of Company Sales)
North America Net sales increased 3.0% in first quarter 2019. Unit
volume increased 2.0%, pricing increased 1.5% and foreign exchange was
negative 0.5%. Organic sales for North America increased 3.5%.
Operating profit in North America decreased 3% in first quarter 2019 to
$249 million, or 190 basis points to 29.2% of Net sales. This decrease
in Operating profit as a percentage of Net sales was primarily due to a
decrease in Gross profit and an increase in Selling, general and
administrative expenses, both as a percentage of Net sales. This
decrease in Gross profit was primarily due to higher raw and packaging
material costs, partially offset by cost savings from the Company’s
funding-the-growth initiatives. This increase in Selling, general and
administrative expenses was primarily due to higher overhead expenses,
driven by higher logistics costs.
In the U.S., Colgate maintained leadership in the toothpaste category
during the quarter with its market share at 34.8% year to date.
Successful products include Colgate TotalSF, Colgate Optic
White Stain Fighter, Colgate Optic White Stain-Less White and Tom’s of
Maine toothpastes. In manual toothbrushes, Colgate maintained its brand
market leadership in the U.S. with its market share in that category at
41.6% year to date, supported by the success of Colgate Extra Clean and
Colgate Gum Health manual toothbrushes.
Products succeeding in other categories include Softsoap Gentle Wash
body wash, Irish Spring 5-in-1 body wash, Fabuloso Complete liquid
cleaner and Suavitel Complete fabric conditioner.
Latin America (23% of Company Sales)
Latin America Net sales decreased 4.5% in first quarter 2019. Unit
volume increased 2.5%, pricing increased 3.5% and foreign exchange was
negative 10.5%. Volume gains were led by Mexico, Brazil and Colombia.
Organic sales for Latin America increased 6.0%.
Operating profit in Latin America decreased 15% in first quarter 2019 to
$232 million, or 330 basis points to 26.1% of Net sales. This decrease
in Operating profit as a percentage of Net sales was primarily due to a
decrease in Gross profit and an increase in Selling, general and
administrative expenses, both as a percentage of Net sales. This
decrease in Gross profit was due to higher raw and packaging material
costs, which included foreign exchange transaction costs, partially
offset by cost savings from the Company’s funding-the-growth
initiatives. This increase in Selling, general and administrative
expenses was due to higher overhead expenses, driven by higher logistics
costs, and increased advertising investment.
Colgate maintained its toothpaste leadership in Latin America during the
quarter, with market share gains in Colombia, Dominican Republic,
Honduras and Uruguay. Products succeeding in the region include Colgate
Natural Extracts, Colgate Total 12 Salud Visible, Colgate Triple Action
Xtra Freshness and Colgate Periogard toothpastes. Colgate’s leadership
in the manual toothbrush category continued throughout the region,
supported by the success of Colgate Pro Cuidado, Colgate 360 Advanced
and Colgate Slim Soft Advanced manual toothbrushes.
Products succeeding in other categories include Colgate Total 12 and
Colgate Periogard mouthwash, Protex Deep Clean and Palmolive Natureza
Secreta bar soaps, Lady Speed Stick Clinical Complete and Speed Stick
Clinical Complete spray deodorants, Axion dish liquid and Fabuloso
Complete liquid cleaner.
Europe (16% of Company Sales)
Europe Net sales decreased 7.0% in first quarter 2019. Unit volume
increased 1.5%, pricing decreased 1.0% and foreign exchange was negative
7.5%. Volume gains were led by the United Kingdom and the Nordic region.
Organic sales for Europe increased 0.5%.
Operating profit in Europe decreased 7% in first quarter 2019 to $151
million, while as a percentage of Net sales it increased 10 basis points
to 25.1% of Net sales. This increase in Operating profit as a percentage
of Net sales was primarily due to an increase in Gross profit partially
offset by an increase in Selling, general and administrative expenses,
both as a percentage of Net sales. This increase in Gross profit was
primarily due to cost savings from the Company’s funding-the-growth
initiatives, partially offset by higher raw and packaging material
costs. This increase in Selling, general and administrative expenses was
due to increased advertising investment, partially offset by lower
overhead expenses.
Colgate maintained its toothpaste leadership in Europe during the
quarter, with toothpaste market share gains in the United Kingdom,
Italy, Switzerland, Denmark and Austria. Products succeeding in oral
care include Colgate Total, Colgate Max White Expert Anti-Stain, Colgate
Natural Extracts Charcoal, elmex, and meridol Pur toothpastes, Colgate
360° Advanced Whole Mouth Health and Colgate Slim Soft Advanced manual
toothbrushes and Colgate Plax mouthwash.
Products succeeding in other categories include Sanex pump body lotions,
Sanex, and Palmolive Clay body washes, Ajax Boost liquid cleaner and
Soupline fabric conditioner.
Asia Pacific (18% of Company Sales)
Asia Pacific Net sales decreased 8.0% during first quarter 2019. Unit
volume decreased 2.5%, pricing was even with the year ago period and
foreign exchange was negative 5.5%. Volume declines in the Greater China
region were partially offset by volume gains in India, Australia,
Thailand and the Philippines. Organic sales for Asia Pacific decreased
2.5%.
Operating profit in Asia Pacific decreased 16% in first quarter 2019 to
$189 million, or 280 basis points to 27.0% of Net sales. This decrease
in Operating profit as a percentage of Net sales was primarily due to a
decrease in Gross profit and an increase in Selling, general and
administrative expenses, both as a percentage of Net sales. This
decrease in Gross profit was primarily due to higher raw and packaging
material costs, which included foreign exchange transaction costs,
partially offset by cost savings from the Company’s funding-the-growth
initiatives. This increase in Selling, general and administrative
expenses was due to higher overhead expenses, driven by higher logistics
costs, and increased advertising investment.
Colgate maintained its toothpaste leadership in the Asia Pacific region
during the quarter with market share gains in the Philippines, Australia
and Pakistan. Products succeeding in the region include Colgate
Naturals, Colgate Total, Colgate Vedshakti, Colgate Panjaved, Colgate
MaxFresh and elmex toothpastes.
Products succeeding in other categories include Colgate Slim Soft
Advanced Volcanic Minerals and Colgate Slim Soft Flex Clean manual
toothbrushes, Palmolive Skin Therapy bar soap, Palmolive Luminous Oils
shower gel and Softlan Divine Pleasures fabric conditioner.
Africa/Eurasia (6% of Company Sales)
Africa/Eurasia Net sales decreased 6.0% during first quarter 2019. Unit
volume was even with the year ago period, pricing increased 7.0% and
foreign exchange was negative 13.0%. Volume gains in Russia and the Gulf
States offset volume declines in South Africa and Saudi Arabia. Organic
sales for Africa/Eurasia increased 7.0%.
Operating profit in Africa/Eurasia decreased 8% in first quarter 2019 to
$46 million, or 40 basis points to 19.2% of Net sales. This decrease in
Operating profit as a percentage of Net sales was due to a decrease in
Gross profit partially offset by a decrease in Selling, general and
administrative expenses, both as a percentage of Net sales. This
decrease in Gross profit was primarily due to higher raw and packaging
material costs, which included foreign exchange transaction costs,
partially offset by cost savings from the Company’s funding-the-growth
initiatives and higher pricing. This decrease in Selling, general and
administrative expenses was due to lower overhead expenses, partially
offset by increased advertising investment.
Colgate maintained its toothpaste leadership in Africa/Eurasia during
the quarter, with market share gains in Turkey, Morocco, Saudi Arabia,
Lebanon, Jordan and Bahrain. Successful products contributing to sales
in the region include Colgate Total 12, Colgate Natural Extracts,
Colgate Optic White Expert White and meridol toothpastes, Colgate 360°
Advanced Whole Mouth Clean and Colgate Slim Soft Advanced manual
toothbrushes and Palmolive Micellar Care shower gel and bar soap.
Hill's Pet Nutrition (15% of Company Sales)
Hill’s Net sales increased 3.0% during first quarter 2019. Unit volume
increased 2.0%, pricing increased 4.0% and foreign exchange was negative
3.0%. Volume gains in the United States and Western Europe were
partially offset by volume declines in South Africa and Russia. Hill’s
organic sales increased 6.0%.
Hill’s Operating profit was even with the year ago quarter, while as a
percentage of Net sales it decreased 80 basis points to 27.3% of Net
sales. This decrease in Operating profit as a percentage of Net sales
was primarily due to a decrease in Gross profit and an increase in
Selling, general and administrative expenses, both as a percentage of
Net sales. This decrease in Gross profit was primarily due to higher raw
and packaging material costs, partially offset by cost savings from the
Company’s funding-the-growth initiatives and higher pricing. This
increase in Selling, general and administrative expenses was due to
increased advertising investment, partially offset by lower overhead
expenses.
Successful products contributing to sales in the United States include
the relaunched Hill’s Science Diet with upgraded recipes, improved
kibble shapes and redesigned package graphics, Hill's Bioactive Recipe,
Hill’s Prescription Diet Metabolic + Urinary and Hill’s Prescription
Diet k/d Early Support.
Successful products contributing to sales internationally include Hill’s
Prescription Diet k/d + Mobility, Hill’s Prescription Diet Metabolic +
Urinary, Hill's Prescription Diet Stews and Hill's Science Diet Perfect
Weight.
***
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer
products company, tightly focused on Oral Care, Personal Care, Home Care
and Pet Nutrition. Colgate sells its products in over 200 countries and
territories around the world under such internationally recognized brand
names as Colgate, Palmolive, elmex, Tom's of Maine, Sorriso, Speed
Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Elta MD,
PCA Skin, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as
Hill’s Science Diet and Hill’s Prescription Diet. For more information
about Colgate’s global business, visit the Company’s website at http://www.colgatepalmolive.com.
To learn more about the Colgate Bright Smiles, Bright Futures® oral
health education program, please visit http://www.colgatebsbf.com.
CL-E
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of
up-to-date information. In particular, market share data is currently
not generally available for certain retail channels, such as eCommerce
or certain discounters. The Company measures year-to-date market shares
from January 1 of the relevant year through the most recent period for
which market share data is available, which typically reflects a lag
time of one or two months. The Company believes that the third-party
vendors it uses to provide data are reliable, but it has not verified
the accuracy or completeness of the data or any assumptions underlying
the data. In addition, market share information reported by the Company
may be different from market share information reported by other
companies due to differences in category definitions, the use of data
from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements (as that term is defined in the U.S. Private Securities
Litigation Reform Act of 1995 or by the Securities and Exchange
Commission (SEC) in its rules, regulations and releases) that set forth
anticipated results based on management’s current plans and assumptions.
Such statements may relate, for example, to sales or volume growth, net
selling price increases, organic sales growth, profit or profit margin
growth, earnings per share levels, financial goals, the impact of
foreign exchange volatility, cost-reduction plans including the Global
Growth and Efficiency Program, tax rates, U.S. tax reform, new product
introductions or commercial investment levels, acquisitions,
divestitures, or legal or tax proceedings, among other matters. These
statements are made on the basis of the Company’s views and assumptions
as of this time and the Company undertakes no obligation to update these
statements whether as a result of new information, future events or
otherwise, except as required by law or by the rules and regulations of
the SEC. Moreover, the Company does not, nor does any other person,
assume responsibility for the accuracy and completeness of these
statements. The Company cautions investors that any such forward-looking
statements are not guarantees of future performance and that actual
events or results may differ materially from those statements. For more
information about factors that could impact the Company’s business and
cause actual results to differ materially from forward-looking
statements, investors should refer to the Company’s filings with the SEC
(including, but not limited to, the information set forth under the
captions “Risk Factors” and “Cautionary Statement on Forward-Looking
Statements” in the Company’s Annual Report on Form 10-K for the year
ended December 31, 2018 and subsequent Quarterly Reports on Form 10-Q).
Copies of these filings may be obtained upon request from the Company’s
Investor Relations Department or on the Company’s website at http://www.colgatepalmolive.com.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial
measures used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions and divestments (non-GAAP). Management believes the organic
sales growth measure provides investors and analysts with useful
supplemental information regarding the Company’s underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
“Geographic Sales Analysis Percentage Changes” for the three months
ended March 31, 2019 vs. 2018 included with this release for a
comparison of organic sales growth to Net sales growth in accordance
with GAAP.
To supplement Colgate’s Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Non-service related postretirement costs, Effective
income tax rate, Net income attributable to Colgate-Palmolive Company
and Diluted earnings per common share are discussed both as reported (on
a GAAP basis) and excluding charges resulting from the Global Growth and
Efficiency Program and, as applicable, the benefit from a foreign tax
matter and the charge related to U.S. tax reform (non-GAAP). These
non-GAAP financial measures exclude items that, either by their nature
or amount, management would not expect to occur as part of the Company’s
normal business on a regular basis, such as restructuring charges,
charges for certain litigation and tax matters, gains and losses from
certain divestitures and certain unusual, non-recurring items. Investors
and analysts use these financial measures in assessing the Company’s
business performance, and management believes that presenting these
financial measures on a non-GAAP basis provides them with useful
supplemental information to enhance their understanding of the Company’s
underlying business performance and trends. These non-GAAP financial
measures also enhance the ability to compare period-to-period financial
results. See “Non-GAAP Reconciliations” for the three months ended
March 31, 2019 and 2018 included with this release for a reconciliation
of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting
process, to evaluate segment and overall operating performance and as
factors in determining compensation. While the Company believes that
these financial measures are useful in evaluating the Company’s
underlying business performance and trends, this information should be
considered as supplemental in nature and is not meant to be considered
in isolation or as a substitute for the related financial information
prepared in accordance with GAAP. In addition, these non-GAAP financial
measures may not be the same as similar measures presented by other
companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company’s ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is a non-GAAP measure
and may not be comparable to similarly titled measures reported by other
companies. See “Condensed Consolidated Statements of Cash Flows” for the
three months ended March 31, 2019 and 2018 for a comparison of free cash
flow before dividends to Net cash provided by operations as reported in
accordance with GAAP.
(See attached tables for first quarter results.)
|
|
|
|
Table 1
|
Colgate-Palmolive Company
|
|
Condensed Consolidated Statements of Income
|
|
For the Three Months Ended March 31, 2019 and 2018
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
2019
|
|
2018
|
|
|
|
|
|
Net sales
|
|
$
|
3,884
|
|
|
$
|
4,002
|
|
|
|
|
|
|
Cost of sales
|
|
1,597
|
|
|
1,594
|
|
|
|
|
|
|
Gross profit
|
|
2,287
|
|
|
2,408
|
|
|
|
|
|
|
Gross profit margin
|
|
58.9
|
%
|
|
60.2
|
%
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
1,365
|
|
|
1,392
|
|
|
|
|
|
|
Other (income) expense, net
|
|
43
|
|
|
33
|
|
|
|
|
|
|
Operating profit
|
|
879
|
|
|
983
|
|
|
|
|
|
|
Operating profit margin
|
|
22.6
|
%
|
|
24.6
|
%
|
|
|
|
|
|
Non-service related postretirement costs
|
|
25
|
|
|
24
|
|
|
|
|
|
|
Interest (income) expense, net
|
|
40
|
|
|
35
|
|
|
|
|
|
|
Income before income taxes
|
|
814
|
|
|
924
|
|
|
|
|
|
|
Provision for income taxes
|
|
214
|
|
|
246
|
|
|
|
|
|
|
Effective tax rate
|
|
26.3
|
%
|
|
26.6
|
%
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
600
|
|
|
678
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests
|
|
40
|
|
|
44
|
|
|
|
|
|
|
Net income attributable to Colgate-Palmolive Company
|
|
$
|
560
|
|
|
$
|
634
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
Basic
|
|
$
|
0.65
|
|
|
$
|
0.72
|
|
Diluted
|
|
$
|
0.65
|
|
|
$
|
0.72
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
Basic
|
|
862.0
|
|
|
875.4
|
|
Diluted
|
|
863.2
|
|
|
879.9
|
|
|
|
|
|
|
|
|
|
Table 2
|
Colgate-Palmolive Company
|
|
Condensed Consolidated Balance Sheets
|
|
As of March 31, 2019, December 31, 2018 and March 31, 2018
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
December 31,
|
|
March 31,
|
|
|
|
2019
|
|
2018
|
|
2018
|
Cash and cash equivalents
|
|
|
$
|
843
|
|
|
$
|
726
|
|
|
$
|
851
|
|
Receivables, net
|
|
|
1,547
|
|
|
1,400
|
|
|
1,644
|
|
Inventories
|
|
|
1,278
|
|
|
1,250
|
|
|
1,312
|
|
Other current assets
|
|
|
465
|
|
|
417
|
|
|
485
|
|
Property, plant and equipment, net
|
|
|
3,821
|
|
|
3,881
|
|
|
4,087
|
|
Other assets, including goodwill and intangibles
|
|
|
4,929
|
|
|
4,487
|
|
|
4,765
|
|
Total assets
|
|
|
$
|
12,883
|
|
|
$
|
12,161
|
|
|
$
|
13,144
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
$
|
6,661
|
|
|
$
|
6,366
|
|
|
$
|
6,709
|
|
Other current liabilities
|
|
|
3,859
|
|
|
3,329
|
|
|
3,821
|
|
Other non-current liabilities
|
|
|
2,573
|
|
|
2,269
|
|
|
2,513
|
|
Total liabilities
|
|
|
13,093
|
|
|
11,964
|
|
|
13,043
|
|
Total Colgate-Palmolive Company shareholders’ equity
|
|
|
(552
|
)
|
|
(102
|
)
|
|
(249
|
)
|
Noncontrolling interests
|
|
|
342
|
|
|
299
|
|
|
350
|
|
Total liabilities and equity
|
|
|
$
|
12,883
|
|
|
$
|
12,161
|
|
|
$
|
13,144
|
|
|
|
|
|
|
|
|
|
Supplemental Balance Sheet Information
|
|
|
|
|
|
|
|
Debt less cash, cash equivalents and marketable securities(1)
|
|
|
$
|
5,781
|
|
|
$
|
5,630
|
|
|
$
|
5,803
|
|
Working capital % of sales
|
|
|
(3.9
|
)%
|
|
(1.7
|
)%
|
|
(2.7
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
Note:
|
(1) Marketable securities of $37, $10 and $55 as of March 31, 2019,
December 31, 2018 and March 31, 2018, respectively, are included in
Other current assets.
|
|
|
|
|
|
|
Table 3
|
Colgate-Palmolive Company
|
|
Condensed Consolidated Statements of Cash Flows
|
|
For the Three Months Ended March 31, 2019 and 2018
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
2019
|
|
2018
|
Operating Activities
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
$
|
600
|
|
|
$
|
678
|
|
Adjustments to reconcile net income including noncontrolling
interests to net cash provided by operations:
|
|
|
|
Depreciation and amortization
|
|
|
128
|
|
|
129
|
|
Restructuring and termination benefits, net of cash
|
|
|
5
|
|
|
(25
|
)
|
Stock-based compensation expense
|
|
|
17
|
|
|
28
|
|
Deferred income taxes
|
|
|
53
|
|
|
13
|
|
Voluntary benefit plan contributions
|
|
|
(102
|
)
|
|
—
|
|
Cash effects of changes in:
|
|
|
|
|
|
Receivables
|
|
|
(145
|
)
|
|
(211
|
)
|
Inventories
|
|
|
(32
|
)
|
|
(33
|
)
|
Accounts payable and other accruals
|
|
|
44
|
|
|
33
|
|
Other non-current assets and liabilities
|
|
|
37
|
|
|
4
|
|
Net cash provided by operations
|
|
|
605
|
|
|
616
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
Capital expenditures
|
|
|
(71
|
)
|
|
(118
|
)
|
Purchases of marketable securities and investments
|
|
|
(27
|
)
|
|
(38
|
)
|
Payment for acquisitions, net of cash acquired
|
|
|
—
|
|
|
(727
|
)
|
Other
|
|
|
—
|
|
|
2
|
|
Net cash used in investing activities
|
|
|
(98
|
)
|
|
(881
|
)
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
Principal payments on debt
|
|
|
(1,774
|
)
|
|
(2,079
|
)
|
Proceeds from issuance of debt
|
|
|
2,076
|
|
|
2,226
|
|
Dividends paid
|
|
|
(366
|
)
|
|
(352
|
)
|
Purchases of treasury shares
|
|
|
(399
|
)
|
|
(351
|
)
|
Proceeds from exercise of stock options
|
|
|
71
|
|
|
119
|
|
Net cash used in financing activities
|
|
|
(392
|
)
|
|
(437
|
)
|
|
|
|
|
|
|
Effect of exchange rate changes on Cash and cash equivalents
|
|
|
2
|
|
|
18
|
|
Net increase (decrease) in Cash and cash equivalents
|
|
|
117
|
|
|
(684
|
)
|
Cash and cash equivalents at beginning of the period
|
|
|
726
|
|
|
1,535
|
|
Cash and cash equivalents at end of the period
|
|
|
$
|
843
|
|
|
$
|
851
|
|
|
|
|
|
|
|
Supplemental Cash Flow Information
|
|
|
|
|
|
Free cash flow before dividends (Net cash provided by operations
less Capital expenditures)
|
|
|
|
|
|
Net cash provided by operations
|
|
|
$
|
605
|
|
|
$
|
616
|
|
Less: Capital expenditures
|
|
|
(71
|
)
|
|
(118
|
)
|
Free cash flow before dividends
|
|
|
$
|
534
|
|
|
$
|
498
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
|
$
|
149
|
|
|
$
|
163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4
|
Colgate-Palmolive Company
|
|
Segment Information
|
|
For the Three Months Ended March 31, 2019 and 2018
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
2018
|
Net Sales
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
$
|
853
|
|
|
$
|
827
|
|
Latin America
|
|
|
889
|
|
|
929
|
|
Europe
|
|
|
602
|
|
|
648
|
|
Asia Pacific
|
|
|
700
|
|
|
759
|
|
Africa/Eurasia
|
|
|
240
|
|
|
255
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
|
3,284
|
|
|
3,418
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
600
|
|
|
584
|
|
|
|
|
|
|
|
Total Net Sales
|
|
|
$
|
3,884
|
|
|
$
|
4,002
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
2018
|
Operating Profit
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
|
$
|
249
|
|
|
$
|
257
|
|
Latin America
|
|
|
232
|
|
|
273
|
|
Europe
|
|
|
151
|
|
|
162
|
|
Asia Pacific
|
|
|
189
|
|
|
226
|
|
Africa/Eurasia
|
|
|
46
|
|
|
50
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
|
867
|
|
|
968
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
|
164
|
|
|
164
|
|
Corporate(1)
|
|
|
(152
|
)
|
|
(149
|
)
|
|
|
|
|
|
|
Total Operating Profit
|
|
|
$
|
879
|
|
|
$
|
983
|
|
Note:
|
(1) Corporate operations include costs related to stock options and
restricted stock units, research and development costs, Corporate
overhead costs, restructuring and related implementation costs and
gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended March
31, 2019 includes charges of $28 related to the Global Growth and
Efficiency Program. Corporate Operating profit (loss) for the three
months ended March 31, 2018 includes charges of $24 related to the
Global Growth and Efficiency Program.
|
|
Table 5
|
Colgate-Palmolive Company
|
|
Geographic Sales Analysis Percentage Changes
|
|
For the Three Months Ended March 31, 2019 vs. 2018
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coupons
|
|
|
|
|
Sales
|
|
|
|
|
|
|
|
|
|
Consumer &
|
|
|
|
|
Change
|
|
Organic
|
|
As Reported
|
|
Organic
|
|
Ex-Divested
|
|
Trade
|
|
Foreign
|
Region
|
|
As Reported
|
|
Sales Change
|
|
Volume
|
|
Volume
|
|
Volume
|
|
Incentives
|
|
Exchange
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
|
(3.0
|
)%
|
|
3.0
|
%
|
|
1.0
|
%
|
|
1.0
|
%
|
|
1.0
|
%
|
|
2.0
|
%
|
|
(6.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe
|
|
(7.0
|
)%
|
|
0.5
|
%
|
|
1.5
|
%
|
|
1.5
|
%
|
|
1.5
|
%
|
|
(1.0
|
)%
|
|
(7.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America
|
|
(4.5
|
)%
|
|
6.0
|
%
|
|
2.5
|
%
|
|
2.5
|
%
|
|
2.5
|
%
|
|
3.5
|
%
|
|
(10.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia Pacific
|
|
(8.0
|
)%
|
|
(2.5
|
)%
|
|
(2.5
|
)%
|
|
(2.5
|
)%
|
|
(2.5
|
)%
|
|
—
|
%
|
|
(5.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Africa/Eurasia
|
|
(6.0
|
)%
|
|
7.0
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
7.0
|
%
|
|
(13.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
|
(6.0
|
)%
|
|
2.0
|
%
|
|
0.5
|
%
|
|
0.5
|
%
|
|
0.5
|
%
|
|
1.5
|
%
|
|
(8.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
3.0
|
%
|
|
3.5
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
1.5
|
%
|
|
(0.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CP Products
|
|
(4.0
|
)%
|
|
2.5
|
%
|
|
1.0
|
%
|
|
1.0
|
%
|
|
1.0
|
%
|
|
1.5
|
%
|
|
(6.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hill’s
|
|
3.0
|
%
|
|
6.0
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
4.0
|
%
|
|
(3.0
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emerging Markets(1)
|
|
(5.5
|
)%
|
|
3.0
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
3.0
|
%
|
|
(8.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developed Markets
|
|
(0.5
|
)%
|
|
3.0
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
2.0
|
%
|
|
1.0
|
%
|
|
(3.5
|
)%
|
Note:
|
(1) Emerging Markets include Latin America, Asia (excluding Japan),
Africa/Eurasia and Central Europe.
|
|
Table 6
|
Colgate-Palmolive Company
|
|
Non-GAAP Reconciliations
|
|
For the Three Months Ended March 31, 2019 and 2018
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
|
|
|
|
2019
|
|
2018
|
|
|
Gross profit, GAAP
|
|
|
|
|
|
|
$
|
2,287
|
|
|
$
|
2,408
|
|
|
|
Global Growth and Efficiency Program
|
|
|
|
|
|
|
11
|
|
|
6
|
|
|
|
Gross profit, non-GAAP
|
|
|
|
|
|
|
$
|
2,298
|
|
|
$
|
2,414
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
Gross Profit Margin
|
|
|
|
|
|
|
2019
|
|
2018
|
|
Change
|
Gross profit margin, GAAP
|
|
|
|
|
|
|
58.9
|
%
|
|
60.2
|
%
|
|
(130
|
)
|
Global Growth and Efficiency Program
|
|
|
|
|
|
|
0.3
|
%
|
|
0.1
|
%
|
|
|
Gross profit margin, non-GAAP
|
|
|
|
|
|
|
59.2
|
%
|
|
60.3
|
%
|
|
(110
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
|
|
|
2019
|
|
2018
|
|
|
Selling, general and administrative expenses, GAAP
|
|
|
|
$
|
1,365
|
|
|
$
|
1,392
|
|
|
|
Global Growth and Efficiency Program
|
|
|
|
|
|
|
(4
|
)
|
|
(5
|
)
|
|
|
Selling, general and administrative expenses, non-GAAP
|
|
|
|
$
|
1,361
|
|
|
$
|
1,387
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
Selling, General and Administrative Expenses as a Percentage of
Net Sales
|
|
|
2019
|
|
2018
|
|
Change
|
Selling, general and administrative expenses as a percentage of Net
sales, GAAP
|
|
|
35.1
|
%
|
|
34.8
|
%
|
|
30
|
|
Global Growth and Efficiency Program
|
|
|
|
|
|
|
(0.1
|
)%
|
|
(0.1
|
)%
|
|
|
Selling, general and administrative expenses as a percentage of Net
sales, non-GAAP
|
35.0
|
%
|
|
34.7
|
%
|
|
30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (Income) Expense, Net
|
|
|
|
|
|
|
2019
|
|
2018
|
|
|
Other (income) expense, net, GAAP
|
|
|
|
$
|
43
|
|
|
$
|
33
|
|
|
|
Global Growth and Efficiency Program
|
|
|
|
(13
|
)
|
|
(13
|
)
|
|
|
Other (income) expense, net, non-GAAP
|
|
|
|
$
|
30
|
|
|
$
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Profit
|
|
|
|
|
|
|
|
2019
|
|
2018
|
|
% Change
|
Operating profit, GAAP
|
|
|
|
$
|
879
|
|
|
$
|
983
|
|
|
(11)%
|
Global Growth and Efficiency Program
|
|
|
|
28
|
|
|
24
|
|
|
|
Operating profit, non-GAAP
|
|
|
|
$
|
907
|
|
|
$
|
1,007
|
|
|
(10)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis Point
|
Operating Profit Margin
|
|
|
|
|
|
|
2019
|
|
2018
|
|
Change
|
Operating profit margin, GAAP
|
|
|
|
|
|
|
22.6
|
%
|
|
24.6
|
%
|
|
(200
|
)
|
Global Growth and Efficiency Program
|
|
|
|
|
|
|
0.8
|
%
|
|
0.6
|
%
|
|
|
Operating profit margin, non-GAAP
|
|
|
|
|
|
|
23.4
|
%
|
|
25.2
|
%
|
|
(180
|
)
|
|
|
Non-Service Related Postretirement Costs
|
|
|
2019
|
|
2018
|
|
|
Non-service related postretirement costs, GAAP
|
|
|
$
|
25
|
|
|
$
|
24
|
|
|
|
Global Growth and Efficiency Program
|
(1
|
)
|
|
(4
|
)
|
|
|
Non-service related postretirement costs, non-GAAP
|
|
|
$
|
24
|
|
|
$
|
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 6
|
Continued
|
Colgate-Palmolive Company
|
|
Non-GAAP Reconciliations
|
|
For the Three Months Ended March 31, 2019 and 2018
|
|
(Dollars in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
Income Before
Income Taxes
|
|
Provision For
Income Taxes(1)
|
|
Net Income
Including
Noncontrolling
Interests
|
|
Net Income
Attributable To
Colgate-
Palmolive
Company
|
|
Effective Income
Tax Rate(2)
|
|
Diluted Earnings
Per Share
|
As Reported GAAP
|
|
|
$
|
814
|
|
|
$
|
214
|
|
|
$
|
600
|
|
|
$
|
560
|
|
|
26.3
|
%
|
|
$
|
0.65
|
Global Growth and Efficiency Program
|
|
|
29
|
|
|
7
|
|
|
22
|
|
|
22
|
|
|
(0.1
|
)%
|
|
0.02
|
Non-GAAP
|
|
|
$
|
843
|
|
|
$
|
221
|
|
|
$
|
622
|
|
|
$
|
582
|
|
|
26.2
|
%
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018
|
|
|
|
Income Before
Income Taxes
|
|
Provision For Income Taxes(1)
|
|
Net Income Including Noncontrolling Interests
|
|
Net Income
Attributable To
Colgate-
Palmolive
Company
|
|
Effective Income
Tax Rate(2)
|
|
Diluted Earnings
Per Share
|
As Reported GAAP
|
|
|
$
|
924
|
|
|
$
|
246
|
|
|
$
|
678
|
|
|
$
|
634
|
|
|
26.6
|
%
|
|
$
|
0.72
|
Global Growth and Efficiency Program
|
|
|
28
|
|
|
8
|
|
|
20
|
|
|
20
|
|
|
0.1
|
%
|
|
0.02
|
Non-GAAP
|
|
|
$
|
952
|
|
|
$
|
254
|
|
|
$
|
698
|
|
|
$
|
654
|
|
|
26.7
|
%
|
|
$
|
0.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The impact of non-GAAP adjustments may not necessarily equal the
difference between “GAAP” and “non-GAAP” as a result of rounding.
|
|
Notes:
|
(1) The income tax effect on non-GAAP items is calculated based upon
the tax laws and statutory income tax rates applicable in the tax
jurisdiction(s) of the underlying non-GAAP adjustment.
|
(2) The impact of non-GAAP items on the Company’s effective tax rate
represents the difference in the effective tax rate calculated with
and without the non-GAAP adjustment on Income before income taxes
and Provision for income taxes.
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20190426005070/en/
Copyright Business Wire 2019